BioMarin Pharmaceutical Story Overview

BMRN -- USA Stock  

USD 93.11  0.78  0.83%

Macroaxis does not monitor all media channels or aggregates social signals for BioMarin Pharmaceutical. But even though we do not provide professional-grade financial sentiment analysis on BioMarin Pharmaceutical, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for BioMarin Pharmaceutical. Check also BioMarin Pharmaceutical Hype Analysis, BioMarin Pharmaceutical Correlation and BioMarin Pharmaceutical Performance.
Bona fide gift to Robert Baffi of 2675 shares of BioMarin Pharmaceutical subject to Section 16
Filed transaction by Biomarin Pharmaceutical I officer. Exempt bona fide gift subject to Rule 16b-3

BioMarin Pharmaceutical Inc insider trading alert for gift of common stock by Robert Baffi, EVP Technical Operations, on January 3, 2018. This event was filed by Biomarin Pharmaceutical I with SEC on 2016-03-07. Statement of changes in beneficial ownership - SEC Form 4. Robert Baffi is currently serves as executive vp of technical operations of BioMarin Pharmaceutical

Story Momentum

This media report from MacroaxisInsider distributed on January 3, 2018 was a factor to the next trading day price decrease.The overall trading delta against the next closing price was 1.91% . The overall trading delta when the story was published against the current closing price is 1.97% .

Similar stores for BioMarin Pharmaceutical

Exercise or conversion by Bienaime Jean Jacques of 2000 shares of BioMarin Pharmaceutical subject to Rule 16b-...news
Filed transaction by Biomarin Pharmaceutical I director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
BioMarin Pharmaceutical Inc. Shares Sold by American Century Companies Inc. - Fairfield Currentnews
BioMarin Pharmaceutical Inc. Shares Sold by American Century Companies Inc. Fairfield CurrentNoticeable Stocks to Watch TherapeuticsMD, Inc. , BioMarin Pharmaceutical Inc. The Newburgh PressView full coverage on Google News
over a week ago at http://www.thecoinguild.com 
Trading Focus Investors Keen on BioMarin Pharmaceutical Inc. as it Makes Waves With Moves - The Coin Guild
news
Trading Focus Investors Keen on BioMarin Pharmaceutical Inc. as it Makes Waves With Moves The Coin GuildBioMarin Pharmaceutical Inc. stock accomplished price worth of 97.79 News LeadingRamping up the expectation BioMarin Pharmaceutical Inc. , SP Global Inc. FinBulletinBiomarin Pharmaceutical INC Shareholder Argentiere Capital Ag Cut Its Position by 3.29 Million as Share Price Rose Flecha 123As Biomarin Pharmaceutical INC Share Value Rose, Argentiere Capital Ag Has Trimmed Stake by 3.29 Million MoneyMakingArticlesView full coverage on Google News
over two weeks ago at http://www.fairfieldcurrent.com 
Primecap Management Co. CA Sells 32,304 Shares of BioMarin Pharmaceutical Inc. - Fairfield Current
news
Primecap Management Co. CA Sells 32,304 Shares of BioMarin Pharmaceutical Inc. Fairfield CurrentUS Bancorp DE Sells 619 Shares of BioMarin Pharmaceutical Inc. PressOracleTrading Watch Investors Keen on Shares of BioMarin Pharmaceutical Inc. as it Makes Headlines With Moves The Coin GuildArgentiere Capital Ag Has Trimmed Stake in Biomarin Pharmaceutical by 3.29 Million Clorox Co Del Holder Miracle Mile Advisors Has Raised Its Position by 2.48 Million as Market Value Rose The FinExaminerKt Stock Declined While Mittleman Brothers Boosted by 1.98 Million Its Position Sectoral Asset Management Lowered Position in Biomarin Pharmac by 12.92 Million EN DigestView full coverage on Google News
over two weeks ago at http://pressoracle.com 
Motley Fool Asset Management LLC Takes 217,000 Position in BioMarin Pharmaceutical Inc. - PressOracle
news
Motley Fool Asset Management LLC Takes 217,000 Position in BioMarin Pharmaceutical Inc. PressOracleMotley Fool Asset Management LLC purchased a new position in BioMarin Pharmaceutical Inc. in the third quarter, according to its most ...
over two weeks ago at http://pressoracle.com 
BioMarin Pharmaceutical Inc. Stake Decreased by US Bancorp DE
news
PressOracleBioMarin Pharmaceutical Inc Is Breakeven Near Simply Wall StWhere BioMarin Pharmaceutical Inc. stock is going ahead Now Reached at 91.47 News Leading BioMarin Q3 Earnings Revenues Surpass Estimates NasdaqFull coverage
over three weeks ago at http://www.fairfieldcurrent.com 
BioMarin Pharmaceutical Inc. EVP Sells 829350.00 in Stock
news
Fairfield CurrentComgest Global Investors SAS Has 3.36 Million Position in BioMarin Pharmaceutical Inc. Marea Informative BioMarin Pharmaceutical Inc. Shares Sold by EULAV Asset Management PressOracleBioMarin Pharma Q3 top line up 17 Vimizim sales up 37 Seeking AlphaFull coverage
over three weeks ago at http://newburghpress.com 
Exercise or conversion by Jeff Ajer of 9000 shares of BioMarin Pharmaceutical subject to Rule 16b-3
news
Filed transaction by Biomarin Pharmaceutical I officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over a month ago at http://pressoracle.com 
8835 Shares in BioMarin Pharmaceutical Inc. Purchased by First Hawaiian Bank
news
PressOracleBioMarin Pharmaceutical Inc. Shares Bought by CMH Wealth Management LLC Baseball Daily NewsAs Biomarin Pharmaceutical INC Shares Rose, Shareholder Highline Capital Management LLC Increased Its ... K ReviewerFull coverage
over a month ago at http://lakelandobserver.com 
Is there Value in Plains All American Pipeline, LP , BioMarin Pharmaceutical Inc.
news
Lakeland ObserverFull coverage
over a month ago at http://www.analystsbuzz.com 
Scan Stocks Buzz BioMarin Pharmaceutical Inc.
news
Voice Of AnalystsFull coverage
over two months ago at http://nysedaily.com 
Sale by Davis George Eric of 616 shares of BioMarin Pharmaceutical
news
Filed transaction by Biomarin Pharmaceutical I officer. General open market or private sale of non-derivative or derivative security
over three months ago at www.macroaxis.com 
Exercise or conversion by Wood Mark of 1250 shares of BioMarin Pharmaceutical subject to Rule 16b-3
Macroaxis News
Filed transaction by the entity officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Number of Employees

Number of Employees Comparative Analysis

  Number of Employees 
      BioMarin Pharmaceutical Comparables 
BioMarin Pharmaceutical is currently under evaluation in number of employees category among related companies. Number of Employees shows total number of permanent full time and part time employees working for a given company and processed through its payroll.
Check also BioMarin Pharmaceutical Hype Analysis, BioMarin Pharmaceutical Correlation and BioMarin Pharmaceutical Performance. Please also try ETF Directory module to find actively-traded exchange traded funds (etf) from around the world.
Search macroaxis.com